Skip to main content
Social Media
Search query
About
Our company
Management
Board of directors
Partners
Compliance overview
Contact us
Our medicines
Reblozyl
®
Science & pipeline
Pipeline
Luspatercept
Sotatercept
ACE-1334
Publications
Luspatercept
Sotatercept
Ace-083
Ace-1332
Patients
Clinical trials
Patient resources
Hematology
Pulmonary
Patient advocacy
Professional organizations
Expanded Access Policy
Careers
Join our team
Who are we?
Values
Working at Acceleron
Meet the accelerators
What's in it for you
How will you grow with us
Benefits
Job opportunities
Home
News
Events & Presentations
Archived Events & Presentations
Stock Information
Analyst Coverage
Financials
Quarterly Results
Annual Meeting
SEC Filings
Governance
Governance Documents
Executive Management
Board of Directors
Committee Composition
Contact the Board
Resources
Investor FAQs
Investor Email Alerts
Investor & Media Contacts
Pricing delayed by 20 minutes.
Quarterly Results
Search query
About
Our company
Management
Board of directors
Partners
Compliance overview
Contact us
Our medicines
Reblozyl
®
Science & pipeline
Pipeline
Luspatercept
Sotatercept
ACE-1334
Publications
Luspatercept
Sotatercept
ACE-083
ACE-1332
Patients
Clinical trials
Patient resources
Hematology
Pulmonary
Patient advocacy
Professional organizations
Expanded Access Policy
Careers
Join our team
Who we are?
Values
Working at Acceleron
Meet the accelerators
What's in it for you
How will you grow with us
Benefits
Job opportunities
Investors & Media
Home
News
Events & Presentations
Archived Events & Presentations
Stock Information
Analyst Coverage
Financials
Quarterly Results
Annual Meeting
SEC Filings
Governance
Governance Documents
Executive Management
Board of Directors
Committee Composition
Contact the Board
Resources
Investor FAQs
Investor Email Alerts
Investor & Media Contacts
Home
News
Events & Presentations
Archived Events & Presentations
Stock Information
Analyst Coverage
Financials
Quarterly Results
Annual Meeting
SEC Filings
Governance
Governance Documents
Executive Management
Board of Directors
Committee Composition
Contact the Board
Resources
Investor FAQs
Investor Email Alerts
Investor & Media Contacts
Financial Summary Table
*Quarterly earnings webcasts are available for approximately one year from the live earnings call.